David Robert Holtgrave

David Robert Holtgrave's AcademicInfluence.com Rankings

Medical

#2620

World Rank

#3051

Historical Rank

Public Health

#391

World Rank

#404

Historical Rank

Epidemiology

#487

World Rank

#509

Historical Rank

medical Degrees

Download Badge

Medical

David Robert Holtgrave's Degrees

PhD Epidemiology Johns Hopkins University
Masters Public Health Johns Hopkins University

Why Is David Robert Holtgrave Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David Robert Holtgrave's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. (2020) (1023)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 (2002) (474)
The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. (2001) (472)
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. (2008) (355)
Alternatives to the randomized controlled trial. (2008) (352)
Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. (2013) (345)
HIV Among Black Men Who Have Sex with Men (MSM) in the United States: A Review of the Literature (2013) (311)
Development of Year 2020 Goals for the National HIV/AIDS Strategy for the United States (2014) (306)
Social capital, poverty, and income inequality as predictors of gonorrhoea, syphilis, chlamydia and AIDS case rates in the United States (2003) (299)
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York (2020) (272)
HIV transmission rates from persons living with HIV who are aware and unaware of their infection (2012) (269)
Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. (1997) (244)
Bridging the gap between the science and service of HIV prevention: transferring effective research-based HIV prevention interventions to community AIDS service providers. (2000) (215)
Randomized Trial of the Effects of Housing Assistance on the Health and Risk Behaviors of Homeless and Unstably Housed People Living with HIV (2010) (202)
The Effects of HIV Stigma on Health, Disclosure of HIV Status, and Risk Behavior of Homeless and Unstably Housed Persons Living with HIV (2009) (201)
COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State (2021) (180)
An overview of the effectiveness and efficiency of HIV prevention programs. (1995) (170)
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021 (2021) (143)
COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State—March 2020 (2020) (143)
Social Capital as a Predictor of Adolescents' Sexual Risk Behavior: A State-Level Exploratory Study (2003) (138)
Trends in diagnoses of HIV infection in the United States, 2002-2011. (2014) (135)
Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. (1998) (134)
Promoting early HIV diagnosis and entry into care. (1999) (132)
Enriching the mix: incorporating structural factors into HIV prevention. (2000) (132)
Costs and Consequences of the US Centers for Disease Control and Prevention's Recommendations for Opt-Out HIV Testing (2007) (128)
Handbook of Economic Evaluation of HIV Prevention Programs (1998) (128)
HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel. (2014) (125)
Dimensions of risk perception for financial and health risks. (1993) (116)
Advances in public health communication. (1995) (116)
NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. (2000) (115)
Cost-effectiveness of a community-level HIV risk reduction intervention. (1998) (110)
Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis. (1993) (107)
Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention. (1996) (106)
Is social capital a protective factor against obesity and diabetes? Findings from an exploratory study. (2006) (105)
Access to Housing as a Structural Intervention for Homeless and Unstably Housed People Living with HIV: Rationale, Methods, and Implementation of the Housing and Health Study (2007) (103)
Assessing racial and ethnic disparities using a COVID-19 outcomes continuum for New York State (2020) (101)
Cost comparison of three HIV counseling and testing technologies. (2003) (100)
HIV intervention research for men who have sex with men: a 7-year update. (2005) (100)
Economic evaluation of HIV prevention programs. (1996) (98)
A systematic review of HIV interventions for black men who have sex with men (MSM) (2013) (98)
Social determinants of tuberculosis case rates in the United States. (2004) (92)
Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. (1996) (91)
Cost-effectiveness of counseling and testing and partner notification: a decision analysis. (1999) (90)
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021 (2021) (90)
Smoking-cessation interventions for U.S. young adults: a systematic review. (2010) (90)
HIV Transmission in the United States: Considerations of Viral Load, Risk Behavior, and Health Disparities (2013) (88)
Associations between internet sex seeking and STI associated risk behaviours among men who have sex with men (2003) (83)
Flavored Tobacco Products in the United States: A Systematic Review Assessing Use and Attitudes. (2016) (81)
Cost‐effectiveness of HIV‐prevention skills training for men who have sex with men (1997) (81)
Maternal Health Locus of Control Beliefs, Utilization of Childhood Preventive Health Services, and Infant Health (1989) (80)
Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs (2002) (78)
Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV (2009) (75)
Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV. (2001) (72)
Cost-utility analysis of the National truth campaign to prevent youth smoking. (2009) (71)
Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. (1998) (71)
Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials. (1991) (69)
The protective value of social capital against teen pregnancy: a state-level analysis. (2006) (69)
Associations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV (2009) (64)
Persistently High Prevalence and Unrecognized HIV Infection Among Men Who Have Sex With Men in Baltimore: The BESURE Study (2011) (62)
Causes of the decline in AIDS deaths, United States, 1995–2002: prevention, treatment or both? (2005) (62)
Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention. (1996) (60)
Physicians' Risk Attitudes, Laboratory Usage, and Referral Decisions (1991) (60)
Prevalence of sexual and drug-related HIV risk behaviors in the U.S. adult population: results of the 1996 National Household Survey on Drug Abuse. (1999) (57)
Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium. (2009) (57)
Economic Evaluation of HIV Risk Reduction Intervention in African‐American Male Adolescents (2000) (57)
USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: A Summary (1996) (55)
Costs, Consequences and Feasibility of Strategies for Achieving the Goals of the National HIV/AIDS Strategy in the United States: A Closing Window for Success? (2012) (55)
Updated annual HIV transmission rates in the United States, 1977-2006. (2009) (54)
Threshold Analysis and Programs for Prevention of HIV Infection (1995) (54)
Homelessness and HIV-Associated Risk Behavior Among African American Men Who Inject Drugs and Reside in the Urban South of the United States (2007) (52)
Unraveling Health Disparities Among Sexual and Gender Minorities: A Commentary on the Persistent Impact of Stigma (2019) (52)
Model-Based Evaluation of Hiv Prevention Interventions (1998) (50)
Impact of counseling in voluntary counseling and testing programs for persons at risk for or living with HIV infection. (2007) (49)
The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis. (1992) (49)
Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis (2006) (48)
Estimated Future HIV Prevalence, Incidence, and Potential Infections Averted in the United States: A Multiple Scenario Analysis (2010) (47)
Syringe Exchange in the United States: A National Level Economic Evaluation of Hypothetical Increases in Investment (2014) (47)
Partner Characteristics and Undiagnosed HIV Seropositivity among Men Who Have Sex with Men Only (MSMO) and Men Who Have Sex with Men and Women (MSMW) in Baltimore (2012) (47)
What works, and what remains to be done, in HIV prevention in the United States. (2006) (46)
Factors influencing attitudes within AIDS service organizations toward the use of research-based HIV prevention interventions. (1999) (46)
Cost–threshold analyses of the National AIDS Demonstration Research HIV Prevention Interventions (2000) (46)
Estimation of Annual HIV Transmission Rates in the United States, 1978–2000 (2004) (46)
Infections Prevented by Increasing HIV Serostatus Awareness in the United States, 2001 to 2004 (2008) (45)
Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. Centers for Disease Control and Prevention. (1998) (45)
Cost-Utility Analysis of the Housing and Health Intervention for Homeless and Unstably Housed Persons Living with HIV (2013) (44)
Estimating the value of preventing a human immunodeficiency virus infection. (1994) (43)
A Method for Evaluating the Economic Efficiency of HIV Behavioral Risk Reduction Interventions (2004) (43)
Encouraging risk reduction: A decision-making approach to message design. (1995) (42)
Can Increasing Awareness of HIV Seropositivity Reduce Infections by 50% in the United States? (2007) (42)
Differences in HIV Risk Behaviors Among Black and White Men Who Have Sex With Men (2007) (41)
Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. (1997) (41)
Utilizing HIV transmission rates to assist in prioritizing HIV prevention services (2004) (40)
Circumcision: a decision analysis of its medical value. (1991) (39)
On the epidemiologic and economic importance of the National AIDS Strategy for the United States. (2010) (39)
Developmental Status, Gender, Age, and Self-Reported Decision-Making Influences on Students' Risky and Preventive Health Behaviors (1995) (39)
Cost‐effectiveness of post‐exposure prophylaxis following sexual exposure to HIV (1998) (38)
Estimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysis. (2002) (38)
Cost and Threshold Analysis of Housing as an HIV Prevention Intervention (2007) (37)
Patient navigation for breast and colorectal cancer in 3 community hospital settings (2012) (37)
Cost-Effectiveness of an HIV/AIDS Prevention Intervention for Gay Men (2004) (37)
Lifetime cost of care for children with human immunodeficiency virus infection. (1997) (33)
A SWOT Analysis of the Updated National HIV/AIDS Strategy for the U.S., 2015–2020 (2015) (33)
Positive Charge: Filling the Gaps in the U.S. HIV Continuum of Care (2015) (33)
Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era. (2013) (32)
HIV incidence and CDC's HIV prevention budget: an exploratory correlational analysis. (2007) (32)
Why don't physicians test for HIV? (2008) (31)
Primary care physicians and their HIV prevention practices. (1996) (30)
Decision-Making in HIV Prevention Community Planning: An Integrative Review (2000) (29)
Factors associated with the acceptance of an AIDS vaccine: an exploratory study. (2004) (29)
Behavioral Factors in Assessing Impact of HIV Treatment as Prevention (2012) (28)
Retention in HIV Care Among Female Sex Workers in the Dominican Republic: Implications for Research, Policy and Programming (2015) (28)
Analysis of media campaign promoting smoking cessation suggests it was cost-effective in prompting quit attempts. (2012) (28)
Toward a Standard Sexual Behavior Data Set for HIV Prevention Evaluation. (1998) (27)
Medical costs averted by HIV prevention efforts in the United States, 1991-2006. (2010) (26)
Elevated COVID-19 outcomes among persons living with diagnosed HIV infection in New York State: Results from a population-level match of HIV, COVID-19, and hospitalization databases. (2020) (25)
The magnitude of key HIV prevention challenges in the United States: implications for a new national HIV prevention plan. (2007) (25)
Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia (2019) (25)
Are Smokers with HIV Using Information and Communication Technology? Implications for Behavioral Interventions (2012) (25)
Postexposure treatment of HIV. (1997) (25)
Unmet HIV Service Needs Among Black Men Who Have Sex with Men in the United States (2013) (25)
The Cost-Effectiveness of Small Group and Community-Level Interventions (1998) (25)
HIV Risk Among Men Who Have Sex with Men Only (MSMO) and Men Who Have Sex with Men and Women (MSMW) in Baltimore (2013) (24)
The development and implementation of the national evaluation strategy of Access to Care, a multi-site linkage to care initiative in the United States. (2014) (23)
Assessing the Cost-Effectiveness of HIV Prevention Interventions (1998) (23)
Estimating the cost of unmet HIV-prevention needs in the United States. (2002) (23)
Cost-Effectiveness of the NIMH Multisite HIV Prevention Intervention (2002) (23)
Cost analyses of peer health worker and mHealth support interventions for improving AIDS care in Rakai, Uganda (2013) (23)
Cost–Utility Analysis of A Female Condom Promotion Program in Washington, DC (2012) (23)
Quantitative Economic Evaluations of HIV-Related Prevention and Treatment Services: A Review (1994) (23)
Will sexual risk behaviour increase after being vaccinated for AIDS? (2006) (22)
The evaluation of HIV counseling-and-testing services: making the most of limited resources. (1997) (22)
Data-Driven Goals for Curbing the U.S. HIV Epidemic by 2030 (2019) (22)
A Review of the Cost-Effectiveness of Interventions to Prevent Sexual Transmission of HIV in the United States (2002) (21)
Current HIV prevention activities for women and gay men among 77 ASOs. (1999) (21)
An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons. (1996) (20)
Setting priorities and community planning for HIV-prevention programs (1994) (20)
Cost and cost threshold analyses for 12 innovative US HIV linkage and retention in care programs (2016) (20)
How HIV Treatment Advances Affect the Cost—Effectiveness of Prevention (2000) (20)
Cumulative Probability of HIV Infection: A Summary Risk Measure for HIV Prevention Intervention Studies (2004) (20)
HIV Transmission Rates in the United States, 2006-2008 (2012) (20)
Cost and Threshold Analysis of Positive Charge, a Multi-site Linkage to HIV Care Program in the United States (2015) (20)
Economic impact of delaying or preventing AIDS in persons with HIV. (1999) (19)
Is the Elimination of HIV Infection within Reach in the United States? Lessons from an Epidemiologic Transmission Model (2010) (19)
Smoking, HIV status, and HIV risk behaviors in a respondent-driven sample of injection drug users in Baltimore, Maryland: The BeSure Study. (2012) (19)
Public health and clinical impact of increasing emergency department-based HIV testing: perspectives from the 2007 conference of the National Emergency Department HIV Testing Consortium. (2011) (19)
Influence of behavioral and social science on public health policymaking. (1997) (19)
Public health communication strategies for HIV prevention: past and emerging roles. (1997) (19)
Consequences of HIV prevention interventions and programs: spectrum, selection, and quality of outcome measures. (2000) (19)
HIV seropositivity rates in outreach-based counseling and testing services: program evaluation. (1998) (19)
Economic Evaluation of a Hospital-Based Palliative Care Program. (2017) (18)
Relationships between public health faculty and decision makers at four governmental levels: a social network analysis (2018) (18)
Issues related to gay and bisexual men's acceptance of a future AIDS vaccine (2005) (18)
A Mixed-Methods Exploration of the Needs of People Living with HIV (PLWH) Enrolled in Access to Care, a National HIV Linkage, Retention and Re-Engagement in Medical Care Program (2018) (18)
Correlates of negative intent to receive an AIDS vaccine: an exploratory study (2004) (18)
Factors affecting engagement between academic faculty and decision-makers: learnings and priorities for a school of public health (2018) (18)
Cost-Effectiveness of a Package of Interventions for Expedited Antiretroviral Therapy Initiation During Pregnancy in Cape Town, South Africa (2014) (17)
Responding to Pandemics: What We’ve Learned from HIV/AIDS (2020) (17)
When is an HIV Infection Prevented and when is it Merely Delayed? (2000) (17)
A Framework to Inform Strategies to Improve the HIV Care Continuum in Low- and Middle-Income Countries. (2016) (17)
Supporting the transfer of HIV prevention behavioral research to public health practice. (2000) (17)
American adults' knowledge of HIV testing availability. (1993) (17)
Who gets how much: funding formulas in federal public health programs. (2007) (17)
Strategic roles for health communication in combination HIV prevention and care programs. (2014) (17)
Stages of sexual readiness and six‐month stage progression among African American pre‐teens (2006) (16)
Determining allocations for HIV-prevention interventions: assessing a change in federal funding policy. (1997) (16)
Experts, Novices, and the St. Petersburg paradox: Is one solution enough? (1989) (16)
Ending HIV in America: Not Without the Power of Community (2019) (16)
Coke Oven Emissions: A Case Study of Technology-Based Regulation (1990) (16)
Year one of HIV prevention community planning: a national perspective on accomplishments, challenges, and future directions. (1996) (16)
Evaluating the Impact of the US National HIV/AIDS Strategy, 2010–2015 (2016) (16)
Brief Report: Economic Implications of Failure to Reduce Incident HIV Infections by 50% by 2005 in the United States (2003) (15)
2015-2020 National HIV/AIDS Strategy Goals for HIV Linkage and Retention in Care: Recommendations From Program Implementers. (2016) (15)
Challenges in defining an optimal approach to formula-based allocations of public health funds in the United States (2007) (15)
Achieving and Advancing the Goals of the National HIV/AIDS Strategy for the United States (2015) (15)
Is post-exposure prophylaxis affordable? (2000) (15)
HIV prevention programs. (1994) (14)
HIV prevention community planning and communities of color: do resources track the epidemic? (2000) (14)
Individual-Level and Partner-Level Predictors of Newly Diagnosed HIV Infection Among Black and White Men Who Have Sex with Men in Baltimore, MD (2015) (14)
Potential and limitations of a ‘test and treat’ strategy as HIV prevention in the United States (2010) (14)
Economic Evaluation of Community-Based HIV Prevention Programs in Ontario: Evidence of Effectiveness in Reducing HIV Infections and Health Care Costs (2015) (14)
Cost analysis and HIV prevention interventions. (1994) (14)
Barriers and Facilitators to the Implementation of a National HIV Linkage, Re-Engagement, and Retention in Care Program. (2017) (13)
Cost-Effectiveness of Community-Level Approaches to HIV Prevention: A Review (2002) (13)
Cost-effectiveness analysis and HIV prevention community planning. (1998) (13)
Cost-utility of HIV Testing Programs Among Men Who Have Sex with Men in the United States (2017) (13)
U.S. HIV Incidence and Transmission Goals, 2020 and 2025. (2017) (13)
Methodological issues in evaluating HIV prevention community planning. (1996) (12)
Attitudes Towards Power in Relationships and Sexual Concurrency Within Heterosexual Youth Partnerships in Baltimore, MD (2015) (12)
Improvements in Health Behaviors and Health Status Among Newly Insured Members of an Innovative Health Access Plan (2013) (12)
HIV Prevention, Cost-Utility Analysis, and Race/Ethnicity: Methodological Considerations and Recommendations (2004) (12)
Working Inside the Firehouse (2013) (12)
What Is a Condom Worth? (1999) (11)
When “Heightened” Means “Lessened”: The Case of HIV Prevention Resources in the United States (2007) (11)
The Economics of HIV Primary Prevention (2000) (11)
Medical costs and quality-adjusted life years associated with smoking: a systematic review (2016) (11)
Strategies for preventing HIV transmission. (2009) (10)
Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States. (2000) (10)
The Role of Quantitative Policy Analysis in HIV Prevention Technology Transfer (2004) (10)
Transurethral prostatectomy versus transurethral dilatation of the prostatic urethra for benign prostatic hyperplasia: a cost-utility analysis. (1993) (10)
Disseminating effective behavioral interventions for HIV prevention: a cost analysis of a risk-reduction intervention for drug users. (2004) (10)
Cost–Utility of Access to Care, a National HIV Linkage, Re-engagement and Retention in Care Program (2018) (9)
Evidence-based efforts to prevent HIV infection: an overview of current status and future challenges. (2007) (9)
Exploring the evolution of engagement between academic public health researchers and decision-makers: from initiation to dissolution (2020) (9)
Cost-Effectiveness of Counseling and Testing to Prevent Sexual Transmission of HIV in the United States (2002) (9)
Correlates of Unprotected Anal Sex with Casual Partners: A Study of Gay Men Living in the Southern United States (2006) (9)
The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness. (2007) (9)
Unpacking Linkage and Reengagement in HIV Care: A Day in the Life of a Positive Charge Care Coordinator. (2015) (9)
Acceptance of a potential HIV/AIDS vaccine among minority women. (2008) (9)
Prophylaxis after Sexual Exposure to HIV (1998) (8)
Implications for HIV prevention programs of the 11 September 2001 terrorist attacks on the United States (2002) (8)
HIV/STD Prevention Interventions for Adolescents: Cost-Effectiveness Considerations (1998) (8)
Novel emergency department registration kiosk for HIV screening is cost-effective† (2016) (8)
Advancing the strategic use of HIV operations research to strengthen local policies and programmes: the Research to Prevention Project (2015) (8)
Barriers and Facilitators to Implementing Access to HIV Care Interventions: A Qualitative Analysis of the Positive Charge Initiative. (2015) (8)
Lifetime costs of HIV/AIDS medical care. (1997) (8)
The HIV/AIDS Prevention Research Synthesis Project: Implications for Federal HIV Prevention Policy (2002) (8)
Core Elements of a National COVID-19 Strategy: Lessons Learned from the US National HIV/AIDS Strategy (2020) (8)
The Cost and Threshold Analysis of Retention in Care (RiC): A Multi-Site National HIV Care Program (2017) (7)
Simplified estimates of HIV incidence and transmission rates for the USA, 2008-2012. (2016) (7)
Apparent declines in the global HIV transmission rate (2009) (7)
Effect of Medicaid Expansions on HIV Diagnoses and Pre-Exposure Prophylaxis Use. (2021) (7)
Implications of Economic Evaluations for National HIV Prevention Policy Makers (2001) (7)
An Online Risk Index for the Cross-Sectional Prediction of New HIV Chlamydia, and Gonorrhea Diagnoses Across U.S. Counties and Across Years (2018) (7)
Chapter 40 - The Public Health Response to the HIV Epidemic in the United States (2004) (7)
A proposed format for tracking the Centers for Disease Control and Prevention's national HIV prevention goal. (2005) (7)
Systematic Development of Trans-Theoretically Based Behavioral Risk Management Programs (1993) (6)
Assessing Social Capital in Kansas: Findings from Quantitative and Qualitative Studies (2007) (6)
Wanted: an effective public health response to hepatitis C virus in the United States. (2008) (6)
Public health errors: costing lives, millions at a time. (2010) (6)
Prioritization methods for HIV community planning. (2000) (6)
Maintaining a Focus on Health Equity During the COVID-19 Vaccine Rollout. (2021) (6)
Determining the Cost-Savings Threshold for HIV Adherence Intervention Studies for Persons with Serious Mental Illness and HIV (2016) (6)
Cost-Effectiveness of Using Mass Media to Prevent Tobacco Use among Youth and Young Adults: The FinishIt Campaign (2019) (6)
An exploration of weekly patterns in HIV-related behaviors: implications for successful interventions and future research (2015) (6)
Cost and Threshold Analysis of the FinishIt Campaign to Prevent Youth Smoking in the United States (2018) (6)
Monitoring Coronavirus Disease 2019 (COVID-19) Through Trends in Influenza-like Illness, Laboratory-confirmed Influenza, and COVID-19—New York State, Excluding New York City, 1 January 2020–12 April 2020 (2020) (6)
Cost-Utility Analysis of Three U.S. HIV Linkage and Re-engagement in Care Programs from Positive Charge (2016) (6)
Cost savings threshold analysis of a capacity-building program for HIV prevention organizations. (2008) (6)
Presidential Elections and HIV-Related National Policies and Programs (2017) (6)
A Multimethod Analysis of Risk Perceptions and Health Behaviors in Children (1997) (5)
Extending access to care across the rural US south: Preliminary results from the Alabama eHealth programme (2019) (5)
Ending the HIV Epidemic: New York’s Quest to Become the First State to Reduce HIV Prevalence (2020) (5)
Setting standards for the Wisconsin HIV Counseling and Testing Program: an application of threshold analysis. (1997) (5)
Employing resource allocation modeling to inform HIV prevention planning for the state of Iowa. (2013) (5)
Preventive services guidelines for primary care clinicians caring for adults and adolescents infected with the human immunodeficiency virus. (1993) (5)
Unmet HIV Service Needs Among Hispanic Men who Have Sex with Men in the United States (2016) (5)
Structural Factors and the National HIV/AIDS Strategy of the USA (2018) (5)
Evaluating HIV prevention efforts to reduce new infections and ensure accountability. (2002) (5)
Using economic threshold analysis to determine the intensity of HIV prevention services for HIV-seropositive persons (2005) (5)
Estimating the Impact of Sexually Transmitted HIV Prevention Interventions: A Comparison of the Proportion of Unprotected Acts to a Regression-Based Approach (1999) (5)
Measuring the value of public health systems. (2009) (5)
Resilient organizations, mobilized communities, and evidence-based HIV prevention programs: examining the influence of a national investment in HIV/AIDS capacity building. (2007) (5)
Ending America’s HIV Epidemic: Why the National HIV/AIDS Strategy Still Matters (2018) (5)
Cost-effectiveness of hepatitis B screening in a mental health institution. (1991) (5)
The Cost-Effectiveness of the Components of a Comprehensive HIV Prevention Program (1998) (5)
Cost and Cost-Effectiveness of Incentives for Viral Suppression in People Living with HIV (2021) (4)
Introduction to special supplement. Monitoring and evaluation of HIV counseling, testing and referral (CTR) and HIV testing services. (2011) (4)
Heuristics, Biases, and Environmental Health Risk Analysis (1994) (4)
The use of memoranda of understanding in fostering inter-agency collaboration: A qualitative study of health services agencies serving vulnerable populations in Baltimore, USA (2013) (4)
Using Resource Allocation Modeling to Inform HIV Prevention Priority Setting for Baltimore-Towson, Maryland (2016) (4)
An Overview of Economic Evaluation Methodologies and Selected Issues in Methods Standardization (1998) (4)
Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19 (2020) (4)
Combination Antiretroviral Therapies for HIV (2002) (4)
Potential Benefits of Expanded COVID-19 Surveillance in the US. (2021) (4)
A National Tracking System for Nonfatal Drug Overdoses. (2022) (4)
The Wire and Urban Health Education (2013) (4)
Predicting EPA's forthcoming CO standards in light of new clinical evidence. (1991) (4)
Teaching Clinical Decision Making in a Family Practice Clerkship (1993) (4)
Improving Access to HIV Care (2015) (3)
HIV prevention evaluation: current contributions and future directions. (2002) (3)
Exploring Changes in Interagency Collaboration Following AIDS United’s Positive Charge (2016) (3)
Generating hypotheses to explain declining HIV infection in four U.S. jurisdictions. (2015) (3)
Barrier Methods for the Prevention of Infectious Diseases: Decades of Condom Research can Inform the Promotion of Face Mask Use (2020) (3)
Communicating environmental health risks: Using the doctor-patient model (1989) (3)
Distribution of Prevention Resources and Impact on Sexual Health in the USA (2013) (3)
Widespread and frequent testing is essential to controlling COVID-19 in the United States (2020) (3)
A framework for gauging the comprehensiveness of governmental HIV prevention programs. (2002) (3)
Extending the methodology of the Committee on Clinical Preventive Service Priorities to HIV-prevention community planning. (2002) (3)
CDC recommendations for opt-out HIV testing. (2009) (3)
Improving Access to HIV Care: Lessons from Five U.S. Sites (2016) (3)
Pre-exposure Prophylaxis for HIV Infection: Preventing Disease or Promoting Sexual Health? (2018) (3)
Evaluating behavioral interventions: need for randomized controlled trials. (1994) (3)
Characteristics of Sexual Partnerships Among Men With Diagnosed HIV Who Have Sex With Men, United States and Puerto Rico-2015-2019. (2020) (2)
A Few Reflections on the Practicality of Economic Evaluation Methods and Conclusions (1998) (2)
HIV prevention: community planning groups. (1995) (2)
University research centers as knowledge translation platforms: leveraging structure, support and resources to enhance multisectoral collaboration and advocacy (2021) (2)
Assessing the population-level prevention effect of emergency department-based HIV testing in the United States: a research framework and commentary. (2011) (2)
The cost-effectiveness of HIV prevention from a managed care perspective. (1998) (2)
Assessing the Cost-effectiveness of Alternative Approaches to HIV Prevention (2002) (2)
Transforming Management of Opioid Use Disorder with Universal Treatment. (2022) (2)
Estimating number of diagnosed persons living with HIV in the United States engaged in unprotected serodiscordant risk behavior with unsuppressed viral load. (2014) (2)
It is Too Early to Discuss HIV Elimination (2010) (2)
Differences and Similarities in HIV Testing Among Men Who have Sex with Men and Women (MSMW) and Men Who Have Sex with Men Only (MSMO) (2012) (2)
Additional Indicators to Measure New HIV Diagnoses: A Response to Chow et al (2016) (1)
Assessing the economic costs and benefits of behavioral interventions. (2001) (1)
Evaluating HIV/AIDS programs in the USand developing countries (2009) (1)
Comments on the Recent Clinical Guidance Statement on HIV Screening (2009) (1)
Advocacy, activism, and lobbying: How variations in interpretation affects ability for academia to engage with public policy (2022) (1)
Science, values and the public health agencies. (2003) (1)
Determining the Most Appropriate Use of Available Regimens for HIV Preexposure Prophylaxis (2022) (1)
Meeting the goals of the US National HIV/AIDS Strategy and Affordable Care Act will require investment in HIV-specific housing supports Stable housing is a prerequisite for HIV treatment adherence and risk reduction Housing assistance is also cost-effective HIV health care (2012) (1)
Valdiserri and Colleagues Respond (1994) (1)
Comments on the Recent Clinical Guidance Statement on HIV Screening (2009) (1)
Track C Epidemiology and Prevention Science (2012) (1)
Economic and Policy Analytic Approaches to Inform the Acceleration of HIV Prevention in the United States: Future Directions for the Field. (2018) (1)
A General Strategy for Single-Subject Research (1989) (1)
An Assessment of the Relationship between Condom Labels and HIV-Related Beliefs and Intentions (2008) (1)
Psychological Measurement and Models of Individual Streams of Behavior (1988) (1)
The Potential Health Benefits of Controlling Hazardous Air Pollutants (1991) (1)
Track E Implementation Science, Health Systems and Economics (2012) (1)
US Tracking System for Nonfatal Drug Overdoses-Reply. (2022) (0)
A Cost and Cost–Threshold Analysis of Implementation of an Evidence-Based Intervention for HIV-Serodiscordant Couples (2019) (0)
HIV PREVENTION : COMMUNITY PLANNING GROUPS. AUTHORS' REPLY (1995) (0)
Xylazine - Medical and Public Health Imperatives. (2023) (0)
Making HIV Testing Routine (2017) (0)
Evaluating the cost-effectiveness of the hospital-based palliative care program at The Johns Hopkins Hospital. (2016) (0)
Human Immunodeficiency Virus Counseling, Testing, Referral, and Partner Notification Services (2017) (0)
In Memoriam–Robin D. Gorsky, PhD, 1948-1995 (1996) (0)
Challenges and opportunities arising from an HIV infection cluster. (1999) (0)
HIV-AIDS in the US: Three policy issues (2005) (0)
Prevention Services with Persons Living with HIV (2014) (0)
Evaluating HIV Transmission Rates for the US National HIV/AIDS Strategy, 2010-2015. (2019) (0)
Erratum: (Preventive Medicine (January/February 1997) (18-25)) (1997) (0)
Establishing an Approach for Designation of Evolving and Emerging Drug Threats. (2023) (0)
States' Methods for Capturing and Reporting Local Responses to Suspected Nonfatal Drug Overdoses. (2023) (0)
"First of all, do no harm:" the sentence with no indirect object. (1991) (0)
A 2023 Agenda for Substance Use Prevention and Treatment in the US. (2023) (0)
Demographic Trends in New HIV Diagnoses in the U.S., 2009-2013. (2016) (0)
The estimated hospital-wide financial impact of a comprehensive inpatient palliative care (PC) program. (2016) (0)
EVALUATING BEHAVIOUR INTERVENTIONS : NEED FOR RANDOMIZED CONTROLLED TRIALS. AUTHORS' REPLY (1994) (0)
Erratum: Associations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV (AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV (2009) 21:6) (2009) (0)
Human Exposure Modeling and the Stream of Behavior (1989) (0)
The Global Engagement in Care Convening: Recommended Actions to Improve Health Outcomes for People Living With HIV. (2016) (0)
PROPHYLAXIS AFTER SEXUAL EXPOSURE TO HIV. AUTHORS' REPLY (1998) (0)
Environmental health resources. (1991) (0)
GENERATING HYPOTHESES TO EXPLAIN D ECLINING H IV I NFECTION I N F OUR U.S. J URISDICTIONS (2015) (0)
When Science and Values Collide: Recalling the Lessons of Evidence-Based HIV Prevention (2017) (0)
Beliefs about cancer screening. (1990) (0)
Cost-Effectiveness: A Key Step in Technology Transfer (2010) (0)
Book Review No Safe Place: Toxic waste, Leukemia, and community action By Phil Brown and Edwin J. Mikkelsen. 260 pp. Berkeley, University of California Press, 1990. $24.95. (1991) (0)
TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David Robert Holtgrave?

David Robert Holtgrave is affiliated with the following schools:

David Robert Holtgrave's Academic­Influence.com Rankings

David Robert Holtgrave's Degrees

Why Is David Robert Holtgrave Influential?

David Robert Holtgrave's Published Works

Published Works

What Schools Are Affiliated With David Robert Holtgrave?

David Robert Holtgrave's AcademicInfluence.com Rankings